Mode
Text Size
Log in / Sign up

Dysregulation of tRNA expression, modification, and tsRNAs is linked to tumor proliferation and therapy resistancetRNA Dysregulation Linked to Cancer Growth and Treatment Resistance

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that dysregulated tRNA and tsRNA pathways are linked to tumor progression and may offer future diagnostic potential.

This systematic review explores the roles of tRNA expression, modifications, and derived small RNAs (tsRNAs) within cancer biology. The scope includes evaluating how these components influence fundamental hallmarks of cancer, including tumor proliferation, metastasis, stress responses, and resistance to therapy.

The authors synthesize evidence indicating that dysregulation in these specific pathways is linked to progression of the disease. Specifically, tRNA-related mechanisms are identified as having potential for future use in cancer diagnosis and determining treatment outcomes. These findings suggest that tRNA pathways may serve as relevant biological markers or targets in oncology.

While the review identifies significant biological links between tRNA dysregulation and cancer progression, it does not provide specific clinical trial data or established treatment protocols. The evidence is currently focused on the potential for advancing precision medicine rather than immediate clinical application. Limitations regarding certain outcomes were not reported.

How this fits prior evidence

This systematic review addresses a gap in understanding the molecular drivers of cancer progression by focusing on tRNA and tsRNA pathways. While other covered findings address specific supportive care measures, such as virtual reality for anxiety or dexmethylphenidate for fatigue, this review focuses on the underlying biological mechanisms of tumor growth and therapy resistance.

Researchers have identified a link between the behavior of tRNA and tsRNA molecules and the progression of cancer. These small RNA components are often disrupted in cancer cells. This imbalance is associated with several factors, including how tumors multiply, how they spread to other parts of the body, and how they respond to cellular stress.

Because these pathways are so involved in cancer biology, they may offer new ways to understand why some treatments work while others do not. The study suggests that these RNA mechanisms could eventually help doctors better diagnose cancer or predict how a patient might respond to specific therapies.

It is important to note that this research focuses on biological links and potential future uses. These findings are currently used for scientific understanding rather than established clinical treatments. More research is needed to determine exactly how these pathways can be safely and effectively used in a medical setting.

What this means for you:
tRNA changes are linked to cancer growth and resistance, offering potential new paths for diagnosis and treatment.

Common questions

What is the role of tRNA in cancer?

The study found that changes in tRNA expression and modification are linked to several parts of cancer biology. These include how tumors grow, how they spread through the body, and how they handle stress. Because these molecules are involved in these processes, they may help researchers understand why some cancers are harder to treat.

Can tRNA be used to treat cancer?

The research suggests that tRNA-related mechanisms have potential for improving cancer diagnosis and treatment outcomes. However, this is currently a biological link rather than an established medical treatment. Doctors are looking into these pathways to help develop more precise ways to manage the disease in the future.

What is the difference between tRNA and tsRNA?

Both tRNA and tsRNAs (derived small RNAs) were found to be linked to tumor proliferation and therapy resistance. When these molecules are dysregulated, they can contribute to how a cancer behaves. Both types of RNA are being studied for their potential roles in understanding and treating various forms of cancer.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedJul 2026
View Original Abstract ↓
Transfer RNA (tRNA) is essential for protein synthesis and undergoes diverse chemical modifications that regulate its stability and function. Dysregulation of tRNA expression and modifications, along with the activity of tRNA-derived small RNAs (tsRNAs) and aminoacyl-tRNA synthetases, has been increasingly linked to cancer development, influencing tumor proliferation, metastasis, stress responses, and therapy resistance. Here we systematically review the biological features of tRNA and its modifications, elucidate their mechanistic roles in various cancers, and explore the emerging functions of tsRNAs and tRNA-modifying enzymes. We also assess the diagnostic and therapeutic potential of targeting tRNA pathways in oncology. These insights provide a foundation for advancing precision medicine approaches by exploiting tRNA-related mechanisms to improve cancer diagnosis and treatment outcomes.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.